MedTrace Logo

a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer

NCT06360653 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-06-25

No results posted yet for this study

Summary

The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer

Conditions

Interventions

RADIATION

Stereotactic Post-operative Radiotherapy for Endometrial Cancer

Patients candidate to receive adjuvant radiotherapy will be assigned to a shorter schedule of 30 Gy in 5 sessions.

Sponsors & Collaborators

  • Accuray Incorporated

    collaborator INDUSTRY

  • ARNAS Civico Di Cristina Benfratelli Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-02
Primary Completion
2026-05-31
Completion
2027-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06360653 on ClinicalTrials.gov